Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Tweet Send to a Friend
Stifel analyst Dae Gon ha reiterated a Buy rating and $74.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


